Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Red cell pyruvate kinase deficiency in Spain: A study of 15 cases
Journal Information
Vol. 148. Issue 1.
Pages 23-27 (January 2017)
Download PDF
More article options
Vol. 148. Issue 1.
Pages 23-27 (January 2017)
Clinical report
Red cell pyruvate kinase deficiency in Spain: A study of 15 cases
Déficit de piruvato cinasa eritrocitaria en España: estudio de 15 casos
Laura Montllora, María del Mar Mañú-Pereiraa,
Corresponding author

Corresponding author.
, Esther Llaudet-Planasa, Pilar Gómez Ramíreza, Julián Sevilla Navarrob, Joan Lluís Vives-Corronsa
a Unidad de Eritropatología, Hospital Clínic de Barcelona, Institut D’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
b Servicio de Hematología y Hemoterapia, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
This item has received
Article information
Full Text
Download PDF
Tables (3)
Table 1. Patients with pyruvate kinase deficiency included. Clinical manifestations, haematological data, enzyme activities and genotype.
Table 2. Family studies; hematologic data, enzyme activities and genotype.
Table 3. Allelic frequencies of pyruvate kinase deficiency mutations; current Zarza 1999 study comparative.
Show moreShow less
Background and objective

Pyruvate kinase deficiency (PKD) is a rare, inherited disease causing chronic hemolysis and anaemia of varying intensity. The genetic heterogeneity of PKD is high and, to this day, over 240 different mutations have been identified.

Patients and methods

15 unrelated patients affected by PKD have been studied. PKLR gene sequencing was performed by SANGER, including the determination of promoter regions, exonic, intronic flanking and 3′ UTR.


Patients were classified into 3 groups based on the intensity of their clinical symptoms: (I) severe and very severe (8 patients); (II) moderate (2 patients), and (III) mild (5 patients). Six out of the 18 alleles found were new mutations which had not been described previously, with the PKLR c.721G>T mutation being the most prevalent (26.67%), followed by the PKLR c.1456C>T mutation (13.33%).


In Spain, the genetic heterogeneity of PKLR is still high but differs from that observed in the previous study carried out in 1998. Total PKLR gene sequencing is necessary for the characterisation of all patients with PKD and for genetic counselling.

Chronic hemolytic anaemia
Pyruvate kinase deficiency
Genetic sequencing
Molecular variants
Antecedentes y objetivo

El déficit de piruvato cinasa (DPK) es una enfermedad hereditaria rara, que cursa con hemólisis crónica y anemia de intensidad variable. Su heterogeneidad genética es elevada, habiéndose descrito unas 240 mutaciones diferentes.

Pacientes y metodología

Se han estudiado 15 pacientes con DPK en los que se ha secuenciado la totalidad del gen PKLR, incluyendo las regiones promotora, exónicas, intrónicas flanqueantes y 3′UTR.


Según la intensidad del cuadro clínico, los pacientes se han clasificado en 3 grandes grupos: I) grave y muy grave (8 pacientes); II) moderado (2 pacientes), y III) leve (5 pacientes). Se han identificado 18 alelos diferentes, de los que 6 son mutaciones nuevas, no descritas con anterioridad, siendo la mutación PKLRc.721G>T la más prevalente (26,67%), seguida de la mutación PKLR c.1456C>T (13,33%). Trece de los 15 pacientes mostraron un genotipo doble heterocigoto y 2 homocigoto.


En España, la heterogeneidad del patrón genético de la PKLR continúa siendo elevada, aunque algo diferente a la observada en un estudio anterior (1998). Se concluye que la secuenciación total del gen PKLR es imprescindible tanto para la caracterización de los pacientes como para la realización del consejo genético.

Palabras clave:
Anemia hemolítica crónica
Déficit de piruvato cinasa
Secuenciación genética
Variantes moleculares


These are the options to access the full texts of the publication Medicina Clínica (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Medicina Clínica (English Edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
No mostrar más